When it comes to recent biotechnology breakthroughs in the healthcare world, industry news sources from Labiotech to Select Science place advancements in gene editing using CRISPR technology at the very top of the list. Labiotech expects approved CRISPR treatments for sickle cell anemia to bring clinical gene editing firmly into the mainstream in 2024. Select Science praises CRISPR technologies from Thermo Fisher Scientific and Merck KGaA/MilliporeSigma for breaking new ground in terms of enhancing gene editing workflow and developing novel therapeutic approaches.
SearchSubmit

Toggle Menu

Locations

Information For

Home>Blog>Biotechnology Breakthroughs: Harnessing the Power of Science for Innovation

# Biotechnology Breakthroughs: Harnessing the Power of Science for Innovation

Published on: March 29, 2024

Biotechnology, as outlined in Biodefense in the Age of Synthetic Biology, has been a part of human innovation for millennia, long before the term was officially coined about a century ago. Today’s biotechnology field is a vast and burgeoning domain of scientific inquiry, presenting promising solutions to some of the most urgent and significant challenges facing humanity. This overview provides a glimpse into the broad spectrum of biotechnology, highlighting exciting projects and developments from leading professionals in the field. From revolutionary healthcare advancements to groundbreaking approaches in agriculture and environmental conservation, biotechnology harnesses the power of scientific research to propel us towards a more sustainable and healthier future. As we delve into the specifics, we uncover the depth and breadth of biotechnology’s potential to transform our world.

## What Is Biotechnology?

Bridging the natural and engineering sciences, biotechnology involves the use of both biological and technological components to improve human health and well-being by addressing key issues in many different areas of science and society. In short, biotechnology exists wherever research and development (R&D) professionals are combining a knowledge of living systems with technological expertise to reach a certain set of objectives.

The broad scope of applications for biotech R&D is reflected in its numerous internal branches. Some of the most popular and promising branches of biotechnology today are…

- Synthetic Biology – Encompassing genetic modalities such as DNA editing, synthetic biology involves the use of technological tools to modify or create biological organisms.

- Agricultural Biotechnology – This field of science might employ techniques from the field of synthetic biology and others to improve agricultural processes and production in both the farming and livestock sectors.

- Environmental Biotechnology – From the development of sustainable crops to the safe disposal of farm waste, environmental biotechnology covers much of the same ground as agricultural biotechnology. However, it goes beyond to encompass biotechnological efforts to protect ecosystems from contamination and restore those that have already been contaminated.

- Industrial Biotechnology – Geared toward industrial and commercial purposes, industrial biotechnology involves the use of biological components to develop new technological processes or functional materials. It has led to breakthroughs in areas that range from biofuel and other chemical products to textiles, cosmetics and packaging.

- Medical Biotechnology – Biotechnology and healthcare have long gone hand in hand. Today, biotech is driving considerable innovation in the prevention, diagnosis and treatment of diseases based on a patient’s genetic characteristics and specific pathology.

## The Latest Breakthroughs in Medical Biotechnology

When it comes to recent biotechnology breakthroughs in the healthcare world, industry news sources from Labiotech to Select Science place advancements in gene editing using CRISPR technology at the very top of the list. Labiotech expects approved CRISPR treatments for sickle cell anemia to bring clinical gene editing firmly into the mainstream in 2024. Select Science praises CRISPR technologies from Thermo Fisher Scientific and Merck KGaA/MilliporeSigma for breaking new ground in terms of enhancing gene editing workflow and developing novel therapeutic approaches.

Biotech is also pushing the boundaries of personalized medicine in 2024. Traditionally, physicians have been forced to take a one-size-fits-all approach to diagnosing and treating diseases and disorders by prescribing and administering the same therapies commonly prescribed and administered to other patients with the same condition. Precision medicine, by contrast, examines a patient’s genetic profile to identify relevant characteristics and then prescribes certain therapies based on those characteristics.

Whether or not they draw upon the power of personalized medicine, biopharmaceuticals are changing the face of drug development today. Select Science presents bi-specific antibodies and oligonucleotide therapeutics as just two among significant biopharmaceuticals poised to make headlines in 2024. Bi-specific antibodies have proven effective in cancer treatment, while oligonucleotide therapeutics antibodies have the potential to address a variety of genetic and infectious diseases.

## Agricultural Biotechnology: Feeding the Future

Biotechnology can make the production of food cheaper, more efficient, greener and easier to manage. It also has the potential to bring food to areas of the world that otherwise go without it. From ongoing population expansion to worsening climate instability, the global food supply is under constant threat in a variety of ways. Scientists see tremendous potential in agricultural biotechnology when it comes to addressing these threats and ensuring that current and future populations get the healthy, nutritious food that they need.

For example, biotech professionals have developed numerous genetically modified crop variants to be more resistant to weeds, pests and adverse weather conditions. In some cases, scientists have designed biotech crops to tolerate particular herbicides to enhance weed control or make it simpler. One of the overarching goals of genetic crop modification is to reduce or eliminate reliance on potentially harmful chemical pesticides.

In some cases, biotech professionals are creating their own natural pesticides safer or better than their synthetic alternatives. Called biopesticides, these natural pesticides have active ingredients that come from natural materials such as plants, animals, bacteria and minerals. The U.S. Environmental Protection Agency currently lists 390 registered biopesticide active ingredients including common kitchen ingredients such as baking soda and canola oil.

## Industrial Biotechnology: The Green Revolution

The combination of “environmental biotechnology” and “industrial biotechnology” might evoke images of a looming conflict. Historically, industrial progress has rarely been associated with environmental sustainability. But today, biotechnology is helping companies incorporate and enhance sustainable industrial processes like never before. The production of biofuel and biodegradable materials are just two ways that industrial biotechnology is contributing to the green revolution.

From ethanol and biodiesel to methanol and butanol, scientists have created several liquid biofuels from plant material and other natural substances. They can also leverage the power of bacterial anaerobic decomposition, to create and capture methane gas. Certain bacteria generate methane naturally when they digest wet waste in an oxygen-free environment.

Biotechnology has also driven considerable advancements in the development of biodegradable materials far better for the environment than plastic and other forms of nondegradable waste. Notably, scientists have created plastic-like biodegradable polymers from substances such as starch and cellulose as well as food and agricultural waste.

Industrial biotechnology holds transformative potential for industries across Missouri and Kansas, regions historically rooted in agriculture and manufacturing. In these heartland states, the adoption of biotechnological innovations could revolutionize local economies and sustainability practices. For instance, Missouri’s rich agricultural sector stands to benefit significantly from biofuel production, leveraging abundant crop residues to produce ethanol and biodiesel, reducing reliance on fossil fuels and opening new markets for farmers. Similarly, Kansas, with its expansive farmlands, can harness biotechnological advancements to transform agricultural waste into valuable biodegradable materials, offering an eco-friendly alternative to traditional plastics that often pollute the environment.

Moreover, both states’ manufacturing sectors could see a paradigm shift with biotechnology. By integrating biodegradable polymers and bio-based chemicals into production lines, companies can reduce their carbon footprint and meet the growing consumer demand for sustainable products. This shift not only positions Missouri and Kansas as leaders in green manufacturing but also attracts investment and creates jobs in cutting-edge research and development sectors.

Additionally, the energy sector, a vital part of both states’ economies, could achieve greater sustainability through biotechnological processes like methane capture from agricultural and municipal waste. This not only provides a renewable energy source but also mitigates greenhouse gas emissions, aligning with both states’ goals to combat climate change and promote environmental stewardship.

In essence, embracing industrial biotechnology offers Missouri and Kansas a pathway to sustainable industrial growth, environmental preservation, and economic diversification. By capitalizing on these innovations, these states can set a precedent for how traditional industries can evolve to meet the challenges of the 21st century.

## The Ethics of Biotechnological Innovation

Of course, any tampering with DNA and RNA, which drive the basic mechanisms of life, is bound to come with its fair share of ethical ramifications. But if scientists proceed with ethical considerations foremost in mind, fears about biotech modalities such as gene editing can be alleviated.

To further these ends, the publication Biotechnology Healthcare encourages scientists to pay close attention to five critical areas of concern. First and foremost, they must take thorough measures to protect human subjects in all clinical trials. Biotech professionals can support equitable care for all by striving to make their products both affordable and widely available. Additionally, protecting an individual’s genome as private information furthers the support for patient rights and security. Because stem cell research remains a hot-button topic for some people, scientists are cautioned to navigate this area of biotechnology with care. Lastly, biotech professionals should consider exactly how their work can and should be used in terms of bioterrorism and the fight against it.

## The Role of Biotechnology in Combatting Global Challenges

Despite the controversial aspects of biotechnology, its benefits cannot be ignored. Based on the information above, it should be obvious that biotechnology has the potential to address and number of global issues.

For instance, the agricultural and green innovations it has engendered play a critical role in the mitigation of climate change. The U.S. Department of Agriculture calls agricultural biotechnology “an important tool for addressing the causes and consequences of climate change” as well as the food insecurity that often goes along with it.

Beyond its positive impact on climate change, biotechnology can increase global food security by producing modified crops optimized for growth and stay fresh longer after harvest. Animal breeders are also using agricultural biotechnology to create improved lines of livestock.

In the aftermath of the global COVID-19 pandemic, there has been an urgent need to invest in new ways to diagnose and treat infectious diseases. This has led to many different biotech R&D projects that strive both to further human understanding of viral infections at the molecular level and develop novel ways to detect and treat these infections.

## Future Trends in Biotechnology

There are a number of promising innovations in the biotech world right now that it is difficult to concentrate on only a few. From the use of artificial intelligence and machine learning in biotechnology to advanced methodologies such as bioprinting and tissue engineering, the future for the field is bright indeed.

However, one cannot discuss biotech industry trends without discussing biotech investment trends. So where is the smart biotech venture capital going and what biotech startups are making news today? Labiotech predicts increased M&A activity through 2024, driving growth for larger companies but making things more difficult for smaller ones. Other trends to expect in 2024 and beyond are increased outsourcing among biotechnology firms and increased partnerships with CROs (Specialty Contract Research Organizations). In summary, Labiotech contends that “2024 stands as a pivotal year that could potentially mark a turning point in the biotech industry.”

## Pursuing College Training in Biotechnology

If you are interested in biotechnology research or the field of biology in general, you can take your curiosity to the next level with a Bachelor of Arts in Biology from Park University. Offered on the school’s main campus in Parkville, Missouri, the Park biology program stresses a fundamental understanding of the biological sciences and offers ample opportunities to conduct laboratory work and complete research projects through both core coursework and “real world” internships. To learn more about the Bachelor of Arts in Biology or any other Park University degree program, fill out a brief digital request for information today.

Blog Categories

###### Share:

What Is Biotechnology? - Park University

8700 NW River Park Drive

Parkville, MO

64152

© 2024 Park University

Official Higher Education Partner of the Kansas City Chiefs

Park University is a private, non-profit, institution of higher learning since 1875.